PaxVax

About:

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

Website: http://paxvax.com

Twitter/X: paxvaxinc

Top Investors: Cerberus Capital Management, Ignition Partners, Blue Haven Initiative, Pharmakon Advisors, Ignition Capital

Description:

PaxVax is a vaccine start-up company developing candidate oral vaccines for influenza, and key infectious diseases. It has developed a proprietary oral vaccine technology based on a common virus called adenovirus. The technology removes the delivery hurdles of traditional injectable vaccines, namely the need for cold storage, needles, and administration by medical personnel. PaxVax was founded in 2007 and is headquartered in Gaithersburg, Maryland.

Total Funding Amount:

$235M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Gaithersburg, Maryland, United States

Founded Date:

2007-01-01

Contact Email:

hr(AT)paxvax.com

Founders:

Daniel Henderson, Kenneth Kelley

Number of Employees:

251-500

Last Funding Date:

2015-12-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai